Топирамат Тева 100 мг

Country: Israel

Language: Russian

Source: Ministry of Health

Active ingredient:

TOPIRAMATE 100 MG

Available from:

TEVA PHARMACEUTICAL INDUST.LTD

ATC code:

N03AX11

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Therapeutic group:

TOPIRAMATE

Therapeutic indications:

Topiramate Teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome . Topiramate Teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.Topiramate Teva is indicated in adults for the prevention of migraines. The use of Topiramate Teva in the acute treatment of migraine has not been studied .

Authorization date:

2011-08-01